Search filters

List of works by Anne Bordron

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia

scientific article published on 29 January 2019

Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia

scientific article published on 9 August 2017

An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome Patients.

scientific article

Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies

scientific article published on September 1, 1997

B cell-ablative therapy: where are we now?

scientific article published on 01 October 2007

CD5 links humoral autoimmunity with B-cell chronic lymphocytic leukemia

scientific article published on 01 May 2007

Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome.

scientific article published on 16 January 2017

Classification of urinary calculi in a pediatric population from Brittany

scientific article published on 15 April 2013

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion

scientific article published on 28 November 2017

Complement System: a Neglected Pathway in Immunotherapy

scientific article published on 01 April 2020

Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression

scientific article published on 28 June 2016

Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system

scientific article

Features of rituximab-induced killing of B lymphocytes

scientific article published on 01 August 2008

Influence of epigenetic in Sjögren's syndrome

scientific article published on 17 October 2017

Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?

scientific article published on 01 June 2007

Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells

scientific article published on November 4, 2011

Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells

scientific article published on 01 September 2008

Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas

scientific article published on September 2004

Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia

scientific article

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy

scientific article published on 03 August 2018

The Innate Part of the Adaptive Immune System

scientific article published on 01 April 2020

The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis

scientific article published on May 15, 1998

The regulatory capacity of B cells directs the aggressiveness of CLL

scientific article published on 12 December 2018

Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.

scientific article

[Comparative study of parathormone and vitamin D measurements by three automats: ADVIA Centaur XP® (Siemens), ISYS® (IDS) and Liaison® (Diasorin)]

scientific article published on 01 July 2014